For neurodegenerative applications, a combination of Dihexa (synaptogenesis), Cerebrolysin (broad neurotrophic support), and Pinealon (epigenetic neuroprotection) addresses connectivity loss, growth factor deficiency, and oxidative vulnerability in parallel
It is never, ever worth the risk
One promising therapeutic strategy involves targeting proteins that become upregulated in the DAM, such as TREM2, chemokine receptor CX3CR1, or adenosine A 2A receptors, with the goal of modulating their activation state
These will boost fiber consumption and support regular bowel movements
On rest days: Take with breakfast for a metabolic boost throughout the day